Research Overview: CJC-1295 Deus Medical
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that has garnered significant attention in peptide research communities. This modified peptide incorporates drug affinity complex (DAC) technology, which substantially extends its half-life compared to traditional GHRH compounds. Researchers at Stroid UK Shop have access to pharmaceutical-grade CJC-1295 Deus Medical for investigating growth hormone pathway mechanisms and pituitary function studies. The compound’s unique molecular structure allows for sustained research observations over extended periods, making it particularly valuable for longitudinal studies examining growth hormone dynamics.
Laboratory Research Applications
Scientific investigations with CJC-1295 focus primarily on understanding growth hormone release patterns and pituitary gland responsiveness. Researchers studying endocrine system function utilise this peptide to examine how modified GHRH analogues interact with somatotroph cells. The compound’s extended pharmacokinetic profile enables researchers to evaluate sustained growth hormone secretion patterns without frequent administration intervals. Studies investigating age-related changes in growth hormone production often incorporate CJC-1295 to understand how peptide modifications affect hormonal cascades. Research facilities examining metabolic pathways frequently analyse how this GHRH analogue influences various physiological markers. Comparative studies between peptides and SARMs mechanisms also benefit from CJC-1295’s well-characterised properties. Laboratory investigations into protein synthesis regulation and cellular regeneration processes represent additional research directions. The compound serves as a valuable tool for understanding how peptide modifications can enhance stability and biological activity in controlled research environments.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Modified Growth Hormone-Releasing Hormone (1-29) |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Purity | ≥98% HPLC |
| Storage | -20°C, protected from light |
| Solubility | Bacteriostatic water |
| Appearance | White lyophilised powder |
Each vial contains pharmaceutical-grade CJC-1295 manufactured under strict quality control protocols. The lyophilised formulation ensures optimal stability during storage and maintains peptide integrity for research applications. Researchers should verify specific batch certificates of analysis for precise molecular data and purity confirmation.
Research Compliance Statement
CJC-1295 Deus Medical is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, clinical use, or any therapeutic applications. All research activities must comply with institutional guidelines and regulatory requirements. Researchers should maintain appropriate laboratory safety protocols when handling this research peptide. This compound is available through our peptides collection for qualified research institutions and licensed laboratories only.
